Correlation Between Palisade Bio and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Unicycive Therapeutics, you can compare the effects of market volatilities on Palisade Bio and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Unicycive Therapeutics.
Diversification Opportunities for Palisade Bio and Unicycive Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Palisade and Unicycive is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Palisade Bio i.e., Palisade Bio and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Palisade Bio and Unicycive Therapeutics
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Palisade Bio is 1.08 times less risky than Unicycive Therapeutics. The stock trades about -0.28 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 41.00 in Unicycive Therapeutics on August 24, 2024 and sell it today you would earn a total of 12.00 from holding Unicycive Therapeutics or generate 29.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Palisade Bio vs. Unicycive Therapeutics
Performance |
| Timeline |
| Palisade Bio |
| Unicycive Therapeutics |
Palisade Bio and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palisade Bio and Unicycive Therapeutics
The main advantage of trading using opposite Palisade Bio and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |